| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/01/2011 | WO2011105474A1 Method for examining acute renal disorder |
| 09/01/2011 | WO2011105466A1 Method for detecting raw pork and detection kit therefor |
| 09/01/2011 | WO2011105424A1 Dendritic cell immunoreceptor stimulant |
| 09/01/2011 | WO2011105253A1 Blood separating agent and blood collection container |
| 09/01/2011 | WO2011105151A1 Composition for plasma and serum separation, and container for blood testing |
| 09/01/2011 | WO2011105130A1 Moisture-absorbing treated material and manufacturing method therefor |
| 09/01/2011 | WO2011105071A1 Method for screening nucleic acid ligand |
| 09/01/2011 | WO2011104964A1 Plant nutritional state diagnosis method, plant nutritional state recovery method, plant nutritional state diagnosis device, and plant nutritional state recovery device |
| 09/01/2011 | WO2011104871A1 Measurement method for physiologically active substance of biological origin, and reagent kit for measurement |
| 09/01/2011 | WO2011104710A1 Device, system and method for in-flow analyte concentration detection |
| 09/01/2011 | WO2011104696A1 Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies |
| 09/01/2011 | WO2011104567A1 Apparatus and method for detection of ammonia in exhaled air |
| 09/01/2011 | WO2011104517A2 Capacitance detection in electrochemical assay |
| 09/01/2011 | WO2011104462A1 Method for identifying the mammalian animal species at the origin of proteins contained in a sample being tested |
| 09/01/2011 | WO2011104380A2 Method for determining at least one piece of information representative of a phase fraction of a fluid in a pipe |
| 09/01/2011 | WO2011104312A1 Improvement of the detection limit of magnetically labelled samples |
| 09/01/2011 | WO2011104309A1 Compounds for the treatment of inflammation and neutropenia |
| 09/01/2011 | WO2011104267A1 Method for determining the antioxidant power of biological and vegetal fluids |
| 09/01/2011 | WO2011103881A1 Method for estimation of non-bicarbonate buffering, strong ion gap, corrected anion gap, plasma protein or albumin concentration |
| 09/01/2011 | WO2011103668A1 Cancer specific peptides and arrays for screening same |
| 09/01/2011 | WO2011103667A1 Agonistic antibodies to trkb receptors and uses thereof |
| 09/01/2011 | WO2011103666A1 Modulation of cytokine-induced chronic inflammatory responses |
| 09/01/2011 | WO2011103642A1 Air fibre testing apparatus |
| 09/01/2011 | WO2011084548A8 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 09/01/2011 | WO2011083391A3 Biomarkers for anti - igf - 1r cancer therapy |
| 09/01/2011 | WO2011063003A3 Peptides and methods for the detection of lyme disease antibodies |
| 09/01/2011 | WO2011061373A8 Quantification of bovine polyomavirus (bpyv) for tracing bovine contamination in the environment |
| 09/01/2011 | WO2011053907A3 Human omental mesothelial cells, methods of isolation and uses thereof |
| 09/01/2011 | WO2011046807A3 Multi-modality contrast and brightfield context rendering for enhanced pathology determination and multi-analyte detection in tissue |
| 09/01/2011 | US20110214194 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway |
| 09/01/2011 | US20110214193 Biomarker for microdomain disease |
| 09/01/2011 | US20110214190 Transgenic reporter mouse and method for use |
| 09/01/2011 | US20110213562 Fluorescent agent concentration measuring apparatus, dose control apparatus, administration system, fluorescent agent concentration measuring method, and dose control method |
| 09/01/2011 | US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 09/01/2011 | US20110213032 Fatty acid c16: 1n7-palmitoleate a lipokine and biomarker for metabolic status |
| 09/01/2011 | US20110213009 Adfp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 09/01/2011 | US20110212981 Method of Determining a Chemotherapeutic Regimen Based on ERCC1 and TS Expression |
| 09/01/2011 | US20110212974 Method for identifying compounds useful for treating and/or preventing disease-associated bone loss |
| 09/01/2011 | US20110212861 Directed synthesis of oligophosphoramidate stereoisomers |
| 09/01/2011 | US20110212859 Radio frequency identifiers for use in biological science |
| 09/01/2011 | US20110212857 Multiplexed Assay Using Encoded Solid Support Matrices |
| 09/01/2011 | US20110212856 Human t2r receptors recognizing a class of bitter molecules from coffee |
| 09/01/2011 | US20110212854 Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
| 09/01/2011 | US20110212853 Novel diagnostic method |
| 09/01/2011 | US20110212851 Salivary transcriptomic and proteomic biomarkers for breast cancer detection |
| 09/01/2011 | US20110212847 Compositions and methods relating to monitoring alcohol consumption and alcohol abuse |
| 09/01/2011 | US20110212845 Biomarkers for predicting the sensitivity and response of protein kinase CK2-mediated diseases to CK2 Inhibitors |
| 09/01/2011 | US20110212843 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors |
| 09/01/2011 | US20110212544 Method and Reagent Kit for Immunological Measurement |
| 09/01/2011 | US20110212543 Method for preparing agglutinatable platelet fragments and the use thereof |
| 09/01/2011 | US20110212542 Labels for electronic detection of individual molecules and methods for their detection |
| 09/01/2011 | US20110212541 Compositions and methods to protect cells by blocking entry of pathogen proteins |
| 09/01/2011 | US20110212540 Probe and method for DNA detection |
| 09/01/2011 | US20110212538 Method for determining an analyte in a water sample by means of a mobile water analysis arrangement |
| 09/01/2011 | US20110212537 Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| 09/01/2011 | US20110212534 Methods for determining levels of 1,25 dihydroxy vitamin d2 and d3 |
| 09/01/2011 | US20110212532 Analytical system and method for its operation |
| 09/01/2011 | US20110212522 Micro-chamber processing apparatus for cell culture and method |
| 09/01/2011 | US20110212511 System for detecting biomolecule with high sensitivity using micro-cantilever |
| 09/01/2011 | US20110212509 Device For And Method Of Extracting A Fraction From A Biological Sample |
| 09/01/2011 | US20110212486 Microscope System, Specimen Observation Method, and Computer Program Product |
| 09/01/2011 | US20110212478 Catheter |
| 09/01/2011 | US20110212477 Lipoprotein-associated markers for cardiovascular disease |
| 09/01/2011 | US20110212473 Mmp activation peptide detection in biological samples |
| 09/01/2011 | US20110212472 Asbestos Exposure, Pleural Mesothelioma and Osteopontin Levels |
| 09/01/2011 | US20110212471 Method for diagnosing atherosclerotic plaques by measurement of cd36 |
| 09/01/2011 | US20110212470 Biomarkers for rheumatoid arthritis |
| 09/01/2011 | US20110212469 Simultaneous Assay of Target and Target-Drug Binding |
| 09/01/2011 | US20110212468 Biomarkers and methods for determining disease progression in nonalcoholic steatohepatitis (nash) |
| 09/01/2011 | US20110212467 INHIBITORS OF dUTPase |
| 09/01/2011 | US20110212466 Thiol-Modified Surface Immobilization Article And Method |
| 09/01/2011 | US20110212465 Armet as a marker for cancer |
| 09/01/2011 | US20110212464 Pacap as a marker for cancer |
| 09/01/2011 | US20110212463 Hybrid target analyte responsive polymer sensor with optical amplification |
| 09/01/2011 | US20110212462 Ultra-sensitive detection of molecules using dual detection methods |
| 09/01/2011 | US20110212461 Prediction of cardiotoxicity |
| 09/01/2011 | US20110212460 Assay for nitrous oxide neurologic syndrome |
| 09/01/2011 | US20110212456 K-ras and B-raf mutations and anti-EGFr antibody therapy |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212448 Gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |
| 09/01/2011 | US20110212440 Cell sorting device |
| 09/01/2011 | US20110212439 Hla alleles associated with adverse drug reactions and methods for detecting such |
| 09/01/2011 | US20110212249 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass and other characteristics in plants |
| 09/01/2011 | US20110212230 Evaluating bacterial lethality of containerized food production |
| 09/01/2011 | US20110212133 Novel Methods of Diagnosis and Treatment of P. Aeruginosa Infection and Reagents Therefor |
| 09/01/2011 | US20110212132 Pathogen for bacterial poultry disease |
| 09/01/2011 | US20110212121 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus |
| 09/01/2011 | US20110212110 Compositions and Methods for Detecting TLR3 |
| 09/01/2011 | US20110212109 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
| 09/01/2011 | US20110212108 Neuregulin/erbb signaling and integrin |
| 09/01/2011 | US20110212107 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212104 Inflammatory bowel disease biomarkers and related methods of treatment |
| 09/01/2011 | US20110212099 Methods of modulating il-22 and il-17 |
| 09/01/2011 | US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof |
| 09/01/2011 | US20110212095 Epitope of cd66c specific to lung adenocarcinoma and antibody recognizing the same |
| 09/01/2011 | US20110212091 Materials and methods for inhibiting cancer cell invasion |
| 09/01/2011 | US20110212088 Anti-paf antibodies |
| 09/01/2011 | US20110212086 GITR Antibodies For The Treatment of Cancer |
| 09/01/2011 | US20110212085 Lung cancer disease targets and uses thereof |